DuPont de Nemours, Inc. is making headlines as Edward D. Breen, an officer at the company, has filed a Form 144 to sell 89,845 shares of common stock. The sale, valued at approximately $13.15 million, comes after Breen exercised employee stock options on November 5, 2026. This transaction highlights ongoing activities within the company and the broader plastics materials and synthetic resins industry.

Background

DuPont de Nemours, Inc. is a prominent player in the plastics materials, synthetic resins, and nonvulcan elastomers sector, categorized under SIC 2821. The company is listed on the New York Stock Exchange under the ticker symbol DD. Recently, DuPont has been active in filing various reports, including a 10-Q on November 3, 2026, and an 8-K on the same day, indicating a period of significant corporate activity.

What the Filing Says

The filing states that Breen sold the shares through a broker-assisted cashless exercise of stock options. The approximate sale date was also noted as November 5, 2026. Breen's decision to sell comes after the acquisition of the shares on the same date, reflecting a strategic financial move.

Impact

This sale may affect various stakeholders, including investors and employees, as it reflects the financial strategies of company leadership. Additionally, it may signal market confidence or personal financial planning within the competitive landscape of the plastics materials and synthetic resins industry.

What's Next

The filing does not say what happens next.